Company Overview

Update
Headquarters:
Tampa, FL
Funding:
$0.00
Categories:
Biotechnology
Description:
Modulation Therapeutics is dedicated towards the rapid and cost effective advancement of early stage first in class molecules targeting the

Detailed Description

Update

Modulation Therapeutics is dedicated towards the rapid and cost effective advancement of early stage first in class molecules targeting the tumor microenvironment. Tumors that home or metastasize to the bone are typically difficult to treat with standard chemotherapy. We propose that strategies to eradicate tumors that home or metastasize to the bone marrow compartment must include disrupting tumor-host interactions. Our lead compound MTI-101 targets CD44, a cell adhesion molecule required for homing to the bone. Our compound shows activity as a single agent using myeloma in vivo models. We project IND filing of our lead compound MTI-101 in the fourth quarter of 2013. Our goal is to develop the lead compound for the treatment of Myeloma a plasma cell tumor which homes to the bone and a disease which currently has no curative therapies available

Funding Rounds (1) - $0.00

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    3802 Spectrum Blvd

    Suite #124

    Tampa, FL 33612

    USA